Lot Consistency Clinical Trial of of Recombinant HPV Bivalent Vaccine in 9 to14 Years Old Healthy Female

NCT05426148 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

540

Enrollment

INDUSTRY

Sponsor class

Conditions

Cervical Intraepithelial Neoplasia
Cervical Cancer
Vaginal Intraepithelial Neoplasia
Vulvar Intraepithelial Neoplasia
Persistent Infection

Interventions

BIOLOGICAL: Recombinant Human Papillomavirus Bivalent (Types 16, 18) Vaccine (Escherichia coli) / Cecolin®

Sponsor

Xiamen Innovax Biotech Co., Ltd

Collaborators

[object Object]
[object Object]